These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3489760)
1. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products. Jakway JP; Usinger WR; Gold MR; Mishell RI; DeFranco AL J Immunol; 1986 Oct; 137(7):2225-31. PubMed ID: 3489760 [TBL] [Abstract][Full Text] [Related]
2. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells. Page DM; DeFranco AL J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499 [TBL] [Abstract][Full Text] [Related]
3. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921 [TBL] [Abstract][Full Text] [Related]
4. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V; Kumar L; Subbarao B J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794 [TBL] [Abstract][Full Text] [Related]
5. The regulation of growth and differentiation of a murine B cell lymphoma. I. Lipopolysaccharide-induced differentiation. Boyd AW; Goding JW; Schrader JW J Immunol; 1981 Jun; 126(6):2461-5. PubMed ID: 6785355 [TBL] [Abstract][Full Text] [Related]
6. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines. Scott DW; O'Garra A; Warren D; Klaus GG J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976 [TBL] [Abstract][Full Text] [Related]
7. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. Boyd AW; Schrader JW J Immunol; 1981 Jun; 126(6):2466-9. PubMed ID: 6785356 [TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. Lee JR; Koretzky GA J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest. Santos-Argumedo L; Gordon J; Heath AW; Howard M Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793 [TBL] [Abstract][Full Text] [Related]
10. Influenza virus hemagglutinin induces differentiation of mature resting B cells and growth arrest of immature WEHI-231 lymphoma cells. Rott O; Cash E J Immunol; 1994 Jun; 152(11):5381-91. PubMed ID: 8189057 [TBL] [Abstract][Full Text] [Related]
11. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma. Ling M; Livnat D; Pillai PS; Scott DW J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509 [TBL] [Abstract][Full Text] [Related]
12. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12. Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220 [TBL] [Abstract][Full Text] [Related]
13. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. Yi AK; Hornbeck P; Lafrenz DE; Krieg AM J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396 [TBL] [Abstract][Full Text] [Related]
14. Regulation of B-cell differentiation: anti-mu antibodies have opposite effects on differentiation stimulated by bacterial lipopolysaccharide and 8-mercaptoguanosine. Rollins-Smith LA; Lawton AR J Mol Cell Immunol; 1988; 4(1):9-19. PubMed ID: 3266925 [TBL] [Abstract][Full Text] [Related]
15. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Pennell CA; Scott DW Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148 [TBL] [Abstract][Full Text] [Related]
16. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089 [TBL] [Abstract][Full Text] [Related]
17. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40. Kelly K; Knox KA Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986 [TBL] [Abstract][Full Text] [Related]
18. Differentiation in the murine B cell lymphoma I.29: inductive capacities of lipopolysaccharide and Mycoplasma fermentans products. Sitia R; Rubartelli A; Deambrosis S; Pozzi D; Hämmerling U Eur J Immunol; 1985 Jun; 15(6):570-5. PubMed ID: 3874069 [TBL] [Abstract][Full Text] [Related]
19. Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. Feuerstein N; Mond JJ J Immunol; 1987 Sep; 139(6):1818-22. PubMed ID: 2442256 [TBL] [Abstract][Full Text] [Related]
20. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]